Company profile: CMA Microdialysis
1.1 - Company Overview
Company description
- Provider of specialized tools for biological research in preclinical settings.
Products and services
🔒
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to CMA Microdialysis
Agilent
HQ: United States
Website
- Description: Provider of scientific and laboratory management solutions for analytical scientists and clinical researchers, offering instruments, software, and HPLC, GC & spectroscopy supplies for chemical analysis; life sciences tools for genomics, proteomics, and cell analysis; diagnostic solutions including pathology and molecular diagnostics; and products such as 8850 GC and NovoCyte Opteon.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Agilent company profile →
Cristcot
HQ: United States
Website
- Description: Provider of drug delivery systems that combine products and specialty drug formulations, including Novel Rescue for UC Flares, a drug in Phase 3 clinical trials designed to achieve clinical remission in ulcerative colitis via mucosal healing within 4 weeks, and a patented hydrocortisone acetate suppository delivered with the Sephure applicator for consistent drug delivery and rapid bioavailability.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Cristcot company profile →
CC Bio
HQ: United Kingdom
Website
- Description: Provider of microbiome-focused therapeutic discovery for diagnosis and treatment. Products include Zeus, a platform to evaluate and optimize therapeutics for precise augmentation of microbial ecology; Athena, a platform developing genetic components for biosensor circuits that sense microbiome diseases; and Dionysus, a program engineering bacterial chassis to sense metabolic changes and record information across human tissues.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full CC Bio company profile →
Surmodics
HQ: United States
Website
- Description: Provider of surface modification and in vitro diagnostic technologies to the healthcare industry, and developer and commercializer of highly differentiated vascular intervention medical devices designed to address unmet clinical needs and engineered to the most demanding requirements.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Surmodics company profile →
Grundium
HQ: Finland
Website
- Description: Provider of smart, portable digital microscope slide scanners leveraging state-of-the-art mobile technology for medical and research specialists. Offerings include Ocus 20 (20x) for fast imaging, intraoperative frozen sections and general pathology; Ocus 40 (40x) for high-resolution histopathology, tumor grading and cytology; and upcoming Ocus M 40 with four-slide tray, upgraded processor and 2TB storage.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Grundium company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for CMA Microdialysis
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to CMA Microdialysis
2.2 - Growth funds investing in similar companies to CMA Microdialysis
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for CMA Microdialysis
4.2 - Public trading comparable groups for CMA Microdialysis
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →